Lv3
370 积分 2021-07-22 加入
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial
7天前
已完结
First-in-Human Study in Healthy Subjects with the Noncytotoxic Monoclonal Antibody OSE-127, a Strict Antagonist of IL-7Rα
9天前
已完结
Targeted depletion of PD-1–expressing cells induces immune tolerance through peripheral clonal deletion
14天前
已完结
IL7RA genetic variants differentially affect IL-7Rα expression and alternative splicing: a role in autoimmune and infectious diseases?
16天前
已完结
Flip the coin: IL-7 and IL-7R in health and disease
21天前
已完结
Complement activation plays a key role in the side‐effects of rituximab treatment
26天前
已完结
Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy
1个月前
已完结
Sepsis and septic shock
1个月前
已完结
Recent advances and evolving concepts in Still’s disease
1个月前
已完结
Precision Immunotherapy to Improve Sepsis Outcomes
1个月前
已完结
皖公网安备34019202002308
